Ă—
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
MorphoSys AG Announces Major Voting Rights Shift - TipRanks.com
Tipranks
Morphosys (MOR) has released an update. MorphoSys AG has announced a significant change in their voting rights distribution following the...
8 hours ago
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT
MorphoSys is dealing with an emerging safety issue related to pelabresib, the experimental treatment for myelofibrosis, STAT has learned.
1 week ago
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters
Morphosys said its takeover by Novartis is still expected to close in the first half of this year, after a news report on a possible drug...
1 week ago
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace
Citing anonymous sources involved in a Phase III trial, STAT News reported Sunday that MorphoSys' pelabresib may worsen the risk of...
1 week ago
Novartis will see modest boost to blood cancer portfolio with MorphoSys acquisition
Clinical Trials Arena
On 4 February 2024, Novartis announced its acquisition of the prominent biopharmaceutical company MorphoSys AG. This deal provides Novartis with...
2 months ago
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Fierce Biotech
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Therapeutics for $750 million.
2 weeks ago
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act
Yahoo Finance
MorphoSys Announces U.S. Antitrust Clearance of Proposed Acquisition by Novartis Under HSR Act ... In this article: ... MorphoSys previously also...
1 month ago
Adam's Biotech Scorecard: Novartis' MorphoSys boondoggle - STAT
STAT
This week in biotechnology: Adam Feuerstein's subscriber-only newsletter digs into MorphoSys, Alzheimer's data, and Pfizer.
6 days ago
MorphoSys AG Announces Major Voting Rights Changes - TipRanks.com
Tipranks
Morphosys (MOR) has released an update. MorphoSys AG has announced a significant update concerning the ownership structure of its voting...
1 day ago
Novartis to acquire cancer-focused MorphoSys for $2.9 billion
Reuters
Drugmaker Novartis AG said it will acquire MorphoSys AG , a developer of cancer treatments, for 2.7 billion euros ($2.9 billion),...
3 months ago